Back to Investors
Verve Ventures

Verve Ventures

Venture Capital

Verve Ventures is a network-driven venture capital firm based in Switzerland that invests in science and technology start-ups across Europe. Founded in 2010, the company connects private and institutional investors with early-stage opportunities.

Portfolio

6

companies

AUM

£500K

under management


Portfolio companies

Zero Point Motion

Zero Point Motion

Zero Point Motion develops ultra-sensitive motion sensors for GPS-denied environments.

Nuclera

Nuclera

Nuclera develops benchtop systems to accelerate protein expression and purification for research laboratories.

C

CellVoyant

CellVoyant is a biotechnology company developing artificial intelligence platforms to advance novel stem cell therapies.

ORCA Computing

ORCA Computing

ORCA Computing develops full-stack photonic quantum computing systems.

Soter Analytics

Soter Analytics

Soter Analytics builds ergonomic wearables and artificial intelligence technology to improve worker safety and prevent workplace injuries.

F

Fractory

An online metal fabrication platform connecting customers with manufacturing partners.


Team

SW

Steffen Wagner

Co-founder

LW

Lukas Weber

Co-founder


Recent investments

Series C
£57.0M

The Series C financing was led by Elevage Medical Technologies with backing from Patient Square Capital and other investors.

"This significant investment demonstrates continued confidence in our team, our eProtein Discovery system, and our potential to revolutionize the way proteins are made. This funding will accelerate our mission to provide ready-to-use benchtop protein screening and making tools to empower protein scientists around the world. We are excited to enhance our support for our customers, enabling them to make proteins for drug discovery more efficiently and effectively for many years to come."
— Michael Chen, CEO
Seed
£7.6M

Octopus Ventures led the seed financing, with participation from Horizons Ventures, Verve Ventures, and Air Street Capital, to commercialise live cell imaging technology.

"University spin-outs like CellVoyant are at the heart of the UK’s thriving biotech ecosystem. CellVoyant sets a new standard in precision and reliability for predicting and controlling stem cell behaviour, which will make cell therapies more accessible to those who need them. We are thrilled to invest into a company that is transforming how patients can benefit from life-changing treatments."
— Uzma Choudry, Lead Biotech Investor
Series A
£12.5M

The Series A round was led by Octopus Ventures, Oxford Science Enterprises, Quantonation, and Verve Ventures.

"Light has a huge part to play in the future of quantum computing as an effective, scalable resource. Our mission is to put photonic systems in the hands of users today so that we deliver value in the short as well as long term,"
— Richard Murray, CEO
Series A
£9.2M

The investment was led by AV8 Ventures with participation from several European funds to advance workplace safety technology.

"Today marks an important milestone for Soter Analytics and our mission to empower organisations to make their workplace safer. Our bespoke technology provides an end-to-end safety solution through AI and machine learning, and this fundraise shows that our investors and partners have recognised the strength of our product. This fresh capital will allow us to invest in research and development and work alongside organisations to help them improve workplace safety, decrease employee turnover, and enable injured workers return to work faster"
— Matthew Hart, Founder and CEO
Seed
£2.6M

The Bristol-based chip company raised £2.6m from Foresight Williams Technology, Verve Ventures, and u-blox to expand its laboratory and team.

"With proven capability to detect motion smaller than the size of a single electron, cavity optomechanical sensing has already had extraordinary benefits for fundamental physics research. Now, we are harnessing this power to improve the inertial sensing devices we’ve come to rely on, bringing untold new potential to drones, VR/AR, indoor navigation and imaging stabilization."
— Ying Li, Founder and CEO
Series A
£6.5M

The Series A round was led by OTB Ventures and will support international expansion and platform development.

"We are thrilled to have raised our latest level of funding and partnering with great investors as we embark on our exciting next stage of growth. The investment will be put towards improving and expanding our services, both in terms of manufacturing capabilities and geography. Since starting operations in Manchester, Fractory has played a vital role in helping to digitise the UK’s metalworks industry, which we believe will be essential for its survival. We can’t wait to expand our platform to help more manufacturers and markets across the globe."
— Martin Vares, Founder and Managing Director